Cotización Aditxt - ADTX

Mejore su cartera: debates en tiempo real e ideas comerciales prácticas.

Premium

Último Precio

1.60

Postura de Compra

1.60

Postura de Venta

1.61

Volume Operado de la Acción

44,778,323

1.59 Rango del Día 3.10

0.0915 Rango de 52 semanas 14.10

Capitalización de Mercado [m]

5.765M

Precio Anterior

1.94

Precio de Apertura

2.18

Hora

420

1.6

(formt)

Última hora de negociación

Volumen financiero

US$ 94,049,757

Precio Promedio Ponderado

2.1003

Volumen promedio (3 m)

4,260,694

Acciones en circulación

3,602,861

Rendimiento del Dividendo

Ratio Precio/Utilidad

-0.18

Beneficio por acción (BPA)

-9.08

turnover

645k

Beneficio neto

-32.7M

Aditxt Inc is a life sciences company which focuses on prolong life and enhance life quality of transplanted patients. The firm develop products designed to induce tolerance to transplanted organs. The firm's immunosuppressive (anti-rejection) drugs has made possible life-saving organ transplantatio... Aditxt Inc is a life sciences company which focuses on prolong life and enhance life quality of transplanted patients. The firm develop products designed to induce tolerance to transplanted organs. The firm's immunosuppressive (anti-rejection) drugs has made possible life-saving organ transplantation procedures as these drugs prevent or delay organ rejection. It is also developing a technology called Apoptotic DNA Immunotherapy (ADi) which utilizes tolerogenic approach that utilizes the body's natural process of cell death, to deliver a modified antigen that signals the immune system to become tolerant to transplanted tissues. Mostrar más

Sector

Pharmaceutical Preparations

Industria

Pharmaceutical Preparations

Sitio web

www.aditxt.com

Sede

Camden, Delaware, USA

Fundado

Aditxt Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker ADTX. The last closing price for Aditxt was US$1.94. Over the last year, Aditxt shares have traded in a share price range of US$ 0.0915 to US$ 14.10.

Aditxt currently has 3,602,861 shares in issue. The market capitalisation of Aditxt is US$6.99 million. Aditxt has a price to earnings ratio (PE ratio) of -0.18.

Aditxt’s Subsidiary Pearsanta to Collaborate with Evofem Biosciences for Targeted U.S. Launch of Endometriosis Diagnostic in Mid-2025

Endometriosis Affects Approximately 190 Million Women Worldwide Non-invasive MET™ Diagnostic Test for Endometriosis Leverages Novel Biomarker: A Specific Deletion in Mitochondrial...

Período †	Variación(Ptos)	Variación %	Apertura	Precio Máximo	Precio Mínimo	Avg. Vol. diario	Precio Promedio Ponderado
1	1.39	661.904761905	0.21	5.12	0.0915	15551935	0.34918476	CS
4	1.16	263.636363636	0.44	5.12	0.0915	4811947	0.34475144	CS
12	0	0	1.6	5.12	0.0915	4260694	1.04284155	CS
26	-1.46	-47.7124183007	3.06	5.12	0.0915	2026235	1.06287886	CS
52	-10.12	-86.3481228669	11.72	14.1	0.0915	1443915	2.3586086	CS
156	-62.4	-97.5	64	1139.6	0.0915	2278198	33.46909812	CS
260	-209.6	-99.2424242424	211.2	1139.6	0.0915	2223782	64.94349384	CS

Volumen
% Mayores Alzas
% Mayores Bajas

Símbolo	Precio	Vol.
CHSNChanson International Holding	US$ 11.22 (269.08%)	14.84M
PEVPhoenix Motor Inc	US$ 1.0607 (205.24%)	223.68M
ENTOEntero Therapeutics Inc	US$ 0.60 (72.20%)	10.42M
BENFBeneficient	US$ 1.8914 (58.94%)	101M
FORDForward Industries Inc	US$ 5.3254 (52.15%)	17.67M
ADDColor Star Technology Company Ltd	US$ 0.2701 (-39.98%)	14.98M
DUOFangDD Network Group Ltd	US$ 2.53 (-32.89%)	28.51M
ICCTiCoreConnect Inc	US$ 0.4102 (-31.50%)	1.68M
ZENAZenaTech Inc	US$ 3.91 (-29.55%)	213.24k
SPAISafe Pro Group Inc	US$ 1.93 (-25.77%)	239.89k
NVDANVIDIA Corporation	US$ 124.92 (1.68%)	244.44M
PEVPhoenix Motor Inc	US$ 1.0607 (205.24%)	228.39M
SQQQProShares UltraPro Short QQQ	US$ 7.43 (-3.63%)	184.42M
NCNCnoco noco Inc	US$ 0.144 (8.60%)	147.34M
BENFBeneficient	US$ 1.8914 (58.94%)	108.3M